跳至主要内容
临床试验/NCT02644785
NCT02644785已完成不适用

Investigation of Anaphylactic Reaction in Cases Undergoing Cardiac By-Pass Surgery

Mustafa Kemal University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2016年1月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Patients number with high tryptase level (> 25 µg/L ).

研究概览

简要总结

The investigators aim to assess tryptase test efficacy for measuring the allergic response to protamine during cardiac bypass surgery. Additionally, the investigators aim to establish a differential diagnosis on the basis of potential allergens or clinical causes.

详细描述

Venous blood samples from cardiac surgery cases will be obtained for tryptase measurement upon admission to the operating room (OR) and immediately prior to and 30 min after protamine infusion initiation. A rapid effect-response-based clinical assessment will be made using clinical and laboratory monitoring data for diagnosis and treatment decisions during protamine infusion, which may complicate the recovery from surgery.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cardiac by-pass cases

排除标准

  • Insulin dependent diabetes
  • Drug allergy history

结局指标

主要结局

Patients number with high tryptase level (> 25 µg/L ).

时间窗: 30 min

Tryptase will be measured using the ImmunoCAP Tryptase kit (Phadia, Uppsala, Sweden), and the cutoff level for elevated tryptase is \>11.5 µg/L. A 25 µg/L cutoff value has been found to be highly suggestive of an İmmunoglobulin E (IgE) -mediated reaction.

次要结局

  • Patients number with allergic reaction involving of 1 or more organ/systems (skin, respiratory, or cardiovascular system) following the study drug infusion. In this study, mainly the cardiovascular and skin symptoms will be focused on.(30 min)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

MENEKSE OKSAR

Assistant Professor

Mustafa Kemal University

研究点 (1)

Loading locations...

相似试验